Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study

scientific article published on 10 August 2009

Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1036257776
P356DOI10.1186/CC7990
P932PMC publication ID2750187
P698PubMed publication ID19664253
P5875ResearchGate publication ID26726135

P50authorHugo Van AkenQ14508140
P2093author name stringAlessandra Orecchioni
Andrea Morelli
Paolo Pietropaoli
Matthias Lange
Christian Ertmer
Martin Westphal
Sebastian Rehberg
Mariadomenica D'Alessandro
Alessandra Bachetoni
Valeria Cecchini
P2860cites workTerlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized studyQ46691567
Septic shock--vasopressin, norepinephrine, and urgencyQ46729640
Comparison of two dose regimens of arginine vasopressin in advanced vasodilatory shockQ46944278
Continuous terlipressin infusion in patients with persistent septic shock and cirrhosis of the liverQ46965282
Continuous versus bolus infusion of terlipressin in ovine endotoxemiaQ50070883
Relation between indocyanine green (ICG) plasma disappearance rate and ICG blood clearance in critically ill patients.Q50736316
Acute endotoxemia in rats induces down-regulation of V2 vasopressin receptors and aquaporin-2 content in the kidney medulla.Q52096231
Monitoring gastric mucosal carbon dioxide pressure using gas tonometry: in vitro and in vivo validation studies.Q52897666
Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.Q54147261
Cholestasis, altered junctional permeability, and inverse changes in sinusoidal and biliary glutathione release by vasopressin and epinephrineQ68342642
Renal microvascular effects of vasopressin and vasopressin antagonistsQ69946506
Physiologic concentrations of arginine vasopressin activate human platelets in vitroQ71045277
Prognostic value of the indocyanine green plasma disappearance rate in critically ill patientsQ78500306
Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better?Q80387730
The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shockQ81251480
Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) GroupQ21195082
Early goal-directed therapy in the treatment of severe sepsis and septic shockQ27860596
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008Q29615602
Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shockQ33195919
Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome?Q33361871
Pressure diuresis and hypertensionQ34060492
The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case seriesQ34340908
Physiology of vasopressin relevant to management of septic shockQ34368620
Vasopressin versus norepinephrine infusion in patients with septic shock.Q34756330
Arginine vasopressin in 316 patients with advanced vasodilatory shock.Q36308724
Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transportQ40565104
Splanchnic tonometry: a review of physiology, methodology, and clinical applicationsQ40644370
Concomitant stimulation by vasopressin of biliary and perfusate calcium fluxes in the perfused rat liverQ41906307
Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trialQ43412778
Differential effects of vasopressin and norepinephrine on vascular reactivity in a long-term rodent model of sepsisQ43449088
Beneficial effects of short-term vasopressin infusion during severe septic shockQ43901842
Terlipressin for norepinephrine-resistant septic shockQ43960661
Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled studyQ44430966
Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shockQ44496952
Terlipressin Infusion in Catecholamine-resistant ShockQ44644649
Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS studyQ44969515
Terlipressin in catecholamine-resistant septic shock patientsQ45065789
Vasopressin plus corticosteroids: the shock duo!Q46111931
Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.Q46111974
P433issue4
P921main subjectsepsisQ183134
septic shockQ1765564
AVPQ12009087
P304page(s)R130
P577publication date2009-08-10
P1433published inCritical CareQ5186602
P1476titleContinuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study
P478volume13

Reverse relations

cites work (P2860)
Q97529284A Furosemide Excretion Stress Test Predicts Mortality in Mice After Sepsis and Outperforms the Furosemide Stress Test During Vasopressin Administration
Q36384718A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock
Q51501472A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock.
Q88816305Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis
Q36070556Bench-to-bedside review: Vasopressin in the management of septic shock
Q64126295Challenges in the management of septic shock: a narrative review
Q35106625Clinical trials comparing norepinephrine with vasopressin in patients with septic shock: a meta-analysis
Q91741502Combination era, using combined vasopressors showed benefits in treating septic shock patients: a network meta-analysis of randomized controlled trials
Q64055906Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials
Q57736170Comparative safety and efficacy of vasopressors for mortality in septic shock: A network meta-analysis
Q55036665Comparison of first-line and second-line terlipressin versus sole norepinephrine in fulminant ovine septic shock.
Q42907348Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock
Q37910252Current management of sepsis in critically ill adult patients
Q46440550Current place of vasopressin analogues in the treatment of septic shock
Q35215743Effects of terlipressin as early treatment for protection of brain in a model of haemorrhagic shock
Q43601541Effects of two different dosing regimens of terlipressin on organ functions in ovine endotoxemia
Q35908131Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock
Q40655602Epidemiology of Vasopressin Use for Adults with Septic Shock.
Q90665537Evaluation of Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Glomerular Filtration Rate and Amikacin Clearance During Early Rat Endotoxemia: Comparison with Traditional Endogenous and Exogenous Biomarkers
Q40147443Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy
Q44899872Hemodynamic effects of continuous versus bolus infusion of terlipressin for portal hypertension: a randomized comparison
Q26777564Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials
Q91795118Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review
Q48177394Perioperative assessment of terlipressin infusion during living donor liver transplantation
Q38272554Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit
Q35559191Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review
Q36980868Right heart in septic shock: prospective observational study
Q33752658Role of vasopressin in current anesthetic practice
Q34047325Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure
Q36454207Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis
Q41414669Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients.
Q90446344Shock - Classification and Pathophysiological Principles of Therapeutics
Q44840415Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock
Q38433744Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.
Q29615429Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012
Q92535791Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis
Q64103730Terlipressin for septic shock patients: a meta-analysis of randomized controlled study
Q90076363Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis
Q42115488Terlipressin or europressin?
Q93064285Terlipressin or norepinephrine in septic shock: do we have the answer?
Q90153140Terlipressin or norepinephrine, or both in septic shock?
Q89414740Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial
Q64087927Terlipressin versus norepinephrine to prevent milrinone-induced systemic vascular hypotension in cardiac surgery patient with pulmonary hypertension
Q87791624The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016)
Q50052469The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).
Q64092466The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis
Q34166143The effects of terlipressin on regional hemodynamics and kidney function in experimental hyperdynamic sepsis
Q37831209The role of vasopressin and terlipressin in catecholamine-resistant shock and cardio-circulatory arrest in children: review of the literature
Q38154892Therapeutic strategies for high-dose vasopressor-dependent shock.
Q35658313Translational research in sepsis - an ultimate challenge?
Q54254903Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates.
Q47355759Use of Terlipressin in an Elderly Patient With Moderate Aortic Valve Stenosis Accompanied by Episodic Atrial Fibrillation During Liver Transplantation: A Case Report
Q36147248Use of inotropes and vasopressor agents in critically ill patients.
Q55004378Using terlipressin in a pediatric patient with septic shock resistant to catecholamines.
Q28068818Vasoactive agents for the treatment of sepsis
Q50245134Vasomotor tone and CBP : monitoring components, pratical and therapeutic approaches
Q52372060Vasoplegia treatments: the past, the present, and the future.
Q26823378Vasopressin V1a and V1b receptors: from molecules to physiological systems
Q21195136Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials
Q37962808Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis
Q58205736Vasopressin improves systemic hemodynamics without compromising mesenteric perfusion in the resuscitation of asphyxiated newborn piglets: a dose–response study
Q64910237Vasopressin in Pediatric Critical Care.
Q24186138Vasopressors for hypotensive shock
Q24234415Vasopressors for hypotensive shock
Q26799763Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis
Q35707635Vasopressors in septic shock: a systematic review and network meta-analysis
Q37814495Year in review 2009: Critical Care--shock
Q87899631[Role of vasopressin in septic shock : critical evaluation]

Search more.